CN101690500B - Bacteriostat, master batch and fiber and manufacturing methods thereof - Google Patents
Bacteriostat, master batch and fiber and manufacturing methods thereof Download PDFInfo
- Publication number
- CN101690500B CN101690500B CN 200910090776 CN200910090776A CN101690500B CN 101690500 B CN101690500 B CN 101690500B CN 200910090776 CN200910090776 CN 200910090776 CN 200910090776 A CN200910090776 A CN 200910090776A CN 101690500 B CN101690500 B CN 101690500B
- Authority
- CN
- China
- Prior art keywords
- weight
- percentage
- bacteriostatic agent
- master batch
- far infrared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Abstract
The invention relates to a bacteriostat, a far infrared propellant, a master batch and a fiber and manufacturing methods thereof, wherein the manufacturing method of the master batch comprises the following steps: carrying out mixed treatment of dehumidification and activation on the bacteriostat which accounts for 8-20% of the master batch by weight and the far infrared propellant which accounts for 10-12% of the master batch by weight; carrying out high-speed mixing, activation and mechanical dispersion treatment on the bacteriostat and the far infrared propellant after the mixed treatment of dehumidification and activation, a carrier which accounts for 64%-78% of the master batch by weight, a coupling agent which accounts for 2-5% of the weight sum of the bacteriostat and the far infrared propellant, an oxytolerant heat resisting agent which accounts for 0.1-0.2% of the carrier by weight and a dispersing agent which accounts for 15-20% of the weight sum of the bacteriostat and the far infrared propellant; cooling the mixture after the dispersion treatment; and casting and granulating the cooled mixture to form a high-speed spinning master batch. The invention produces the master batch containing the bacteriostat and the far infrared propellant into the fiber, so that the fiber has double functions of bacteriostasis and health care.
Description
Technical field
The present invention relates to a kind of bacteriostatic agent, master batch and fiber and manufacture method thereof, particularly a kind of have antibiotic and master batch, fiber and manufacture method thereof far-infrared transmitting function, belongs to textile technology field.
Background technology
Fast development along with modern industrial technology, the technology of textile industry is also with rapid changepl. never-ending changes and improvementsly progressive, after fibre in differentiation, the fiber of several functions has appearred again in recent years, for example has fiber of better fungistatic effect etc., simultaneously, other fibers such as far infrared emission fiber with health role are also in the urgent need to producing.
But present bacteriostatic fiber fungistatic effect is low, and bacteria resistance function gives fabric with dipping and coated mode, and after repeatedly washing, function will fade away, and persistence is poor; Adopt master batch such as the antibacterial agent etc. that will have various functions by special spinning processing technique to be mixed into equably the method for preparing fiber in fibre-forming polymer although also have in prior art, but the method can only prepare the fiber with simple function, and can't join simultaneously with having multi-functional efficient solid phase inorganic substances the synthetic fibers that prepare the high-speed spinning with several functions in fibre-forming polymer as the solid phase inorganic substances with several functions such as bacteria resistance function and health-care effects well.
Summary of the invention
The embodiment of the present invention provides a kind of bacteriostatic agent, and this bacteriostatic agent comprises at least:
Mixture of silver nitrate, accounting for the bacteriostatic agent percentage by weight is 54-70%, wherein, described mixture of silver nitrate comprises that to account for the bacteriostatic agent percentage by weight be the silver nitrate of 36-40% and accounts for the nanoscale zeolite that the bacteriostatic agent percentage by weight is 18-30%; Described silver nitrate exists with the form of silver nitrate aqueous solution;
Titanium oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%;
Zinc oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%.
Above-mentioned bacteriostatic agent is owing to containing the silver ion more than 6-10% thereby having efficient bacteria resistance function.
The embodiment of the present invention provides a kind of manufacture method of bacteriostatic agent, and this manufacture method comprises:
It is that the granularity of 36-40% and silver nitrate is implanted less than or equal to the silver nitrate in the silver nitrate aqueous solution of 100 nanometers and accounted in the nanoscale zeolite that the bacteriostatic agent percentage by weight is 18-30% that silver nitrate is accounted for the bacteriostatic agent percentage by weight, forms mixture; Described mixture is made granularity and is the silver zeolite that contains of 100 nanometers left and right after the drying that dewaters, pulverizing, grinding;
Described silver zeolite and the granularity of containing accounted for less than or equal to 100 nanometers titanium oxide and the zinc oxide that the bacteriostatic agent percentage by weight is respectively 15-23% and 15-23% and mix, form bacteriostatic agent.
The manufacture method of above-mentioned bacteriostatic agent is main body owing to adopting special silver ion at the silver nitrate more than 50%, adds zinc oxide and titanium oxide to make the bacteriostatic agent with efficient bacteria resistance function after particle is processed.
The embodiment of the present invention provides a kind of far infrared cast charge, this far infrared cast charge comprises that granularity is less than or equal to alundum (Al2O3) and the silica of 100 nanometers, and it is 80-90% that described alundum (Al2O3) accounts for far infrared cast charge percentage by weight, and it is 10-20% that described silica accounts for far infrared cast charge percentage by weight.
Above-mentioned far infrared cast charge due to the alundum (Al2O3) with certain proportioning and silica, makes it have the health care of the acceptable far infrared transmission line of human body.
The embodiment of the present invention provides a kind of manufacture method of far infrared cast charge, and this manufacture method comprises:
Be that the silica of 10-20% carries out air-flow crushing, ground and mixed with accounting for alundum (Al2O3) that far infrared cast charge percentage by weight is 80-90%, accounting for far infrared cast charge percentage by weight;
Particle after the pulverizing ground and mixed is carried out silane surface process, make the far infrared cast charge.
The manufacture method of above-mentioned far infrared cast charge will be made the far infrared cast charge through alundum (Al2O3) and silica that granularity is processed, make this far infrared cast charge with health role.
The embodiment of the present invention provides a kind of master batch, and this master batch comprises:
Bacteriostatic agent, the percentage by weight that accounts for master batch is 8-20%;
The far infrared cast charge, the percentage by weight that accounts for master batch is 10-12%;
Carrier, the percentage by weight that accounts for master batch is 64-78%;
Coupling agent accounts for the 2-5% of bacteriostatic agent and far infrared cast charge weight sum;
The oxytolerant heat-resistant agent, accounting for vehicle weight percentage is 1-2 ‰;
Dispersant accounts for the 15-20% of bacteriostatic agent and far infrared cast charge weight sum;
Wherein, described bacteriostatic agent comprises at least:
Mixture of silver nitrate, accounting for the bacteriostatic agent percentage by weight is 54-70%, wherein, described mixture of silver nitrate comprises that to account for the bacteriostatic agent percentage by weight be the silver nitrate of 36-40% and accounts for the nanoscale zeolite that the bacteriostatic agent percentage by weight is 18-30%; Described silver nitrate exists with the form of silver nitrate aqueous solution;
Titanium oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%;
Zinc oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%;
Described far infrared cast charge comprises: granularity is less than or equal to alundum (Al2O3) and the silica of 100 nanometers, and it is 80-90% that described alundum (Al2O3) accounts for far infrared cast charge percentage by weight, and it is 10-20% that described silica accounts for far infrared cast charge percentage by weight.
Above-mentioned master batch has health care efficient antibacterial and the far infrared emission owing to containing bacteriostatic agent and far infrared cast charge.
The embodiment of the present invention provides a kind of manufacture method of master batch, and this manufacture method comprises:
Be the bacteriostatic agent of 8-20% and to account for the master batch percentage by weight be the far infrared cast charge of the 10-12% activation mixed processing that dehumidifies to accounting for the master batch percentage by weight;
With after dehumidifying activation mixed processing to account for the master batch percentage by weight be the bacteriostatic agent of 8-20% and account for the far infrared cast charge that the master batch percentage by weight is 10-12%, carrier with the 64-78% that accounts for the master batch percentage by weight, with the coupling agent that accounts for bacteriostatic agent and far infrared cast charge weight sum 2-5%, be the oxytolerant heat-resistant agent of 1-2 ‰ and the dispersant that accounts for bacteriostatic agent and far infrared cast charge weight sum 15-20% with accounting for vehicle weight percentage, carry out height and stir the mechanical dispersion treatment of activation;
Mixture after dispersion treatment is carried out cooling processing;
Cooled mixture is carried out the casting pelletizing, form the high speed spinning master batch.
The manufacture method of above-mentioned master batch is processed the generation master batch to bacteriostatic agent and far infrared cast charge, makes it have efficient antibacterial far infrared emission health care.
The embodiment of the present invention provides a kind of fiber, and this fiber comprises:
Moisture less than or equal to the 400ppm master batch, the percentage by weight that accounts for fiber is 10-20%;
Moisture less than or equal to 400ppm and the dried high-speed spinning section identical with carrier in described master batch, the percentage by weight that accounts for fiber is 80-90%;
The master batch that wherein said master batch provides for the embodiment of the present invention.
Above-mentioned fiber is because the master batch that contains efficient functions of bacteriostasis and health-care has corresponding function.
The embodiment of the present invention provides a kind of manufacture method of fiber, and this manufacture method comprises:
After (10-20%) moisture all master batches and the even mixing of dried high-speed spinning section less than or equal to 400ppm than (80-90%), be spun into the FDY drawn fiber by melting high-speed spinning through one-step method; By melting high-speed spinning, be spun into the POY protofilament; By the middling speed melt spinning, be spun into the MOY protofilament.
Above-mentioned fiber is made fiber by having health care master batch efficient antibacterial and the far infrared emission, and is had health care efficient antibacterial and the far infrared emission.
Below by drawings and Examples, technical scheme of the present invention is described in further detail.
Description of drawings
Fig. 1 is the flow chart of master batch manufacture method embodiment of the present invention;
Fig. 2 is the flow chart of fibre manufacture embodiment of the present invention.
Embodiment
The embodiment of the present invention provides a kind of bacteriostatic agent, this bacteriostatic agent comprises at least: mixture of silver nitrate, accounting for the bacteriostatic agent percentage by weight is 54-70%, wherein, described mixture of silver nitrate comprise account for the bacteriostatic agent percentage by weight be 36-40% silver nitrate and account for the nanoscale zeolite that the bacteriostatic agent percentage by weight is 18-30%, described silver nitrate exists with the form of silver nitrate aqueous solution; Titanium oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%; It is 15-23% that zinc oxide accounts for the bacteriostatic agent percentage by weight.
Wherein, mixture of silver nitrate, titanium oxide and the zinc oxide optimum weight percentage that accounts for bacteriostatic agent is respectively 60%, 20% and 20%.
Above-mentioned bacteriostatic agent is that silver nitrate more than 50% is that main body has efficient bacteria resistance function owing to adopting silver ion.
The embodiment of the present invention provides a kind of manufacture method of bacteriostatic agent, and this manufacture method comprises:
It is that the granularity of 36-40% and silver nitrate is implanted less than or equal to the silver ion in the silver nitrate aqueous solution of 100 nanometers and accounted in the nanoscale zeolite that the antibacterial agent percentage by weight is 18-30% that silver nitrate is accounted for the bacteriostatic agent percentage by weight, forms mixture; With this mixture through dewatering, forming the argentiferous zeolite mixture after drying, air-flow crushing, grinding;
Above-mentioned argentiferous zeolite mixture and granularity are accounted for less than or equal to 100 nanometers titanium oxide and the zinc oxide that the bacteriostatic agent percentage by weight is respectively 15-23% and 15-23% mix, form bacteriostatic agent.
The manufacture method of above-mentioned bacteriostatic agent, be main body owing to adopting special silver ion at the silver nitrate more than 50% (in silver nitrate, silver ion is more than 50%), add zinc oxide and titanium oxide to make the bacteriostatic agent with efficient bacteria resistance function after particle is processed.
The embodiment of the present invention provides a kind of far infrared cast charge, this far infrared cast charge comprises that granularity is less than or equal to alundum (Al2O3) and the silica of 100 nanometers, and the percentage by weight that alundum (Al2O3) accounts for the far infrared cast charge is 80-90%, and the percentage by weight that silica accounts for the far infrared cast charge is 10-20%.
Wherein, alundum (Al2O3), the silica optimum weight percentage that accounts for the far infrared cast charge is respectively 85%, 15%.
Above-mentioned far infrared cast charge due to the alundum (Al2O3) with certain proportioning and silica, makes it have the health care of far infrared emission.
The embodiment of the present invention provides a kind of manufacture method of far infrared cast charge, and this manufacture method comprises:
Be the silica of 10-20% with accounting for alundum (Al2O3) that far infrared cast charge percentage by weight is 80-90%, accounting for far infrared cast charge percentage by weight, form powder particle through air-flow crushing, ground and mixed;
Powder particle after pulverizing, ground and mixed is carried out silane surface process, can make the far infrared cast charge.
The manufacture method of above-mentioned far infrared cast charge will be made the far infrared cast charge through alundum (Al2O3) and silica that granularity is processed, make this far infrared cast charge with health role.
The embodiment of the present invention provides a kind of master batch, and this master batch comprises: bacteriostatic agent, and accounting for the master batch percentage by weight is 8-20%; The far infrared cast charge, accounting for the master batch percentage by weight is 10-12%; Carrier, accounting for the master batch percentage by weight is 64-78%; Coupling agent accounts for the 2-5% of bacteriostatic agent and far infrared cast charge weight sum; The oxytolerant heat-resistant agent, accounting for vehicle weight percentage is 1-2 ‰; Dispersant accounts for the 15-20% of bacteriostatic agent and far infrared cast charge weight sum;
Wherein, the bacteriostatic agent that bacteriostatic agent provides for the invention described above embodiment, the concrete component of this bacteriostatic agent does not repeat them here referring to the description in the invention described above embodiment.
Wherein, above-mentioned carrier can be polyamide fibre 6 (PA6), polyamide fibre 66 (PA66), terylene (PET) or the dried high-speed spinning section of polypropylene fibre (PP) etc., above-mentioned coupling agent can be silane coupler, above-mentioned oxytolerant heat-resistant agent can be pentaerythritol ester, and above-mentioned dispersant can be vinyl polymer wax.
Above-mentioned master batch has health care efficient antibacterial and the far infrared emission owing to containing bacteriostatic agent and far infrared cast charge.
As shown in Figure 1, be the flow chart of master batch manufacture method embodiment of the present invention, this manufacture method specifically comprises:
Step 101, be the bacteriostatic agent of 8-20% and to account for the master batch percentage by weight be the far infrared cast charge of the 10-12% activation mixed processing that dehumidifies to accounting for the master batch percentage by weight;
Above-mentioned steps 101 specifically comprises:
Two kinds of reagent are put into drying box:
At 120 ℃ of constant temperature, carry out the Air exhaust of 2 hours respectively; At 130 ℃ of constant temperature, carry out the Air exhaust of 1 hour; At 140-142 ℃ of constant temperature, carry out the Air exhaust of 1 hour.
After step 102, the activation process that will dehumidify to account for the master batch percentage by weight be the bacteriostatic agent of 8-20% and account for the far infrared cast charge that the master batch percentage by weight is 10-12%, carrier with the 64-78% that accounts for the master batch percentage by weight, with the coupling agent that accounts for bacteriostatic agent and far infrared cast charge weight sum 2-5%, be the oxytolerant heat-resistant agent of 1-2 ‰ and the dispersant that accounts for bacteriostatic agent and far infrared cast charge weight sum 15-20% with accounting for vehicle weight percentage, carry out height and stir the mechanical dispersion treatment of activation;
Above-mentioned steps 102 specifically comprises:
Bacteriostatic agent after dehumidifying activation mixed processing and far infrared cast charge were stirred 6-8 minute under the mixing speed of the whipping temp of 120-140 ℃, 1300rpm;
In the mixture of the bacteriostatic agent after stirring and far infrared cast charge, add the silane coupler that accounts for bacteriostatic agent and far infrared cast charge weight sum 2-5%, and at the whipping temp of 120-130 ℃, stirred 2-3 minute under the mixing speed of 1300rpm;
In the mixture of the bacteriostatic agent after stirring, far infrared cast charge, silane coupler, adding the percentage by weight that accounts for master batch after dewatering is the carrier of 64-78%, and at the whipping temp of 120-130 ℃, stirs 6-8 minute under the mixing speed of 1300rpm; The carrier that the present embodiment adopts is PA6, also can be PA66, PET or PP, and carrier is moisture less than or equal to 400ppm except PP;
In the mixture of the bacteriostatic agent after stirring, far infrared cast charge, silane coupler and carrier, add and account for the oxytolerant heat-resistant agent that vehicle weight percentage is 1-2 ‰, and at the whipping temp of 120-130 ℃, stirred 2-3 minute under the mixing speed of 1300rpm, above-mentioned oxytolerant heat-resistant agent is pentaerythritol ester;
In the mixture of the bacteriostatic agent after stirring, far infrared cast charge, silane coupler, carrier and oxytolerant heat-resistant agent, add the dispersant that accounts for bacteriostatic agent and far infrared cast charge weight sum 15-20%, and at the whipping temp of 120-130 ℃, stirred 2-3 minute under the mixing speed of 1300rpm, above-mentioned dispersant is the PE macromolecule wax;
Step 103, the mixture after dispersion treatment is carried out cooling processing;
It is that the cold water agitator of 3 tons/hour of the cooling water inflows of 25-28 ℃ stirred cooling 8-12 minute that mixture after dispersion treatment is put into temperature, and described mixture temperature is down to below 45 ℃; Or add in the cooling and stirring machine cooling and stirring to described mixture temperature to be down to below 45 ℃;
Step 104, cooled mixture is carried out melting casting pelletizing, form the high speed spinning master batch.
Cooled mixture is put into twin-screw casting machine, carry out melting, make melt fully cut dispersion, and in the situation that keep predetermined mobility, directly cooling, cut-out of casting entry, granulation.Above-mentioned high speed spinning master batch must be through dewatering with the equal standard-required of dried high-speed spinning section.
The manufacture method of above-mentioned master batch is carried out a series of processing to bacteriostatic agent and far infrared cast charge and is made master batch, makes it have health care efficient antibacterial and the far infrared emission.
The embodiment of the present invention provides a kind of fiber, and this fiber comprises:
Moisture less than or equal to the 400ppm master batch, the percentage by weight that accounts for fiber is 10-20%;
Moisture less than or equal to 400ppm and the dried high-speed spinning section identical with carrier in master batch, the percentage by weight that accounts for fiber is 80-90%;
Wherein, the master batch that master batch provides for the invention described above embodiment, the concrete component of this master batch does not repeat them here referring to the description in the invention described above embodiment.
Above-mentioned fiber, has dual-use function owing to containing the master batch with efficient functions of bacteriostasis and health-care, namely have the lethal effect of human body harmful bacteria and the effect that the far infrared of the useful 5-25 mum wavelength of human body is launched, it is Ag that this functional fibre adopts silver nitrate aqueous solution
+H substance, and employing nanoscale zeolite is that base material is with Ag
+Implant, like this can be successfully the Ag that content is larger
+Implant in the middle of the nanoscale zeolite, revest among fiber above-mentioned Ag
+By enclosed pasture gravitation, both are firmly adsorbed, Ag with electronegative bacterium
+Be penetrated into and destroyed the bacterial cell synthase activity in bacterial cell, make cell lose the fission ability and death, reach the purpose of sterilization, the Ag on dead bacterial cell afterwards
+Dissociate, pass through again enclosed pasture gravitation contact sterilization again, go round and begin again, make this fiber sterilization have long-lasting; Above-mentioned relatively large Ag
+More than the 650 kind of harmful bacteria such as harmful Escherichia coli and staphylococcus aureus had suppress and killing action, and can to the indivedual positions of human body or the fungi take Candida albicans as representative that produced by ectocine, have stronger killing action.
As shown in Figure 2, be the flow chart of fibre manufacture embodiment of the present invention, the method specifically comprises:
The above-mentioned speed of spinning is 4500-4600m/min;
Wherein, the percentage by weight of above-mentioned master batch and the section of dried high-speed spinning can be (10-20%): (80-90%), select 10%: 90% herein, the speed of spinning protofilament is made as 4300-4400m/min, the temperature of spinning manifold is made as 260-265 ℃, extruder temperature is made as 265-270 ℃, spinning window temperature is made as 19-21 ℃, spinning window humidity is made as 65%-70%, first fine finish is controlled at the just 7%-8% of fine weight, can be made into the POY protofilament;
In addition, can also add bullet to the POY protofilament and process, form elastomer; Above-mentionedly the POY protofilament is added bullet process and to comprise: the POY protofilament is carried out interior drafting false twisting add that bullet is processed and common adding plays the drawing-off processing; The POY protofilament is after interior drafting false twisting adds the bullet processing, can obtain elastic fibers DTY, it spins speed for 650-750 m/min, the linear velocity of elasticizer frictional disk is 1.5-1.7 with the ratio D/Y of the speed of fiber process frictional disk, drafting multiple is 1.25-1.27, heating-up temperature is 160-180 ℃, and the dosage that refuels is controlled at the 2.5%-3.5% of fibre weight, forms after treatment the efficient antibacterial far infrared emission elastomer of DTY.
Step 204, by the middling speed melt spinning, be spun into the MOY protofilament.
The above-mentioned speed of spinning is 400-450m/min, and the MOY protofilament can obtain elastic fibers DTY or drawn fiber FDY through adding bullet or drawing-off processing.
Efficient bacteriostatic agent and efficient far infrared cast charge in above-mentioned efficient antibacterial and far infrared emission fiber belong to inorganic solid matter, and the embodiment of the present invention all adopts nanometer particle, and its activity is strong especially, and bacteriostasis rate and far infrared emissivity are higher; The present invention has reached the effect of thorough dispersion by taking following a plurality of step: 1. Ag
+High-temperature activation dispersion for main component and other components; 2. high speed machine dispersed with stirring; 3. high-purity low melting point dispersant disperses; 4. the high rotating speed parallel dual-screw of high fusion pressure melt disperses.By these means, the solid phase inorganic matter is fully disperseed in high-viscosity melt, the efficient antibacterial and far infrared emission master batch of making, the mobility of suitable high speed spinning melt is carried out high speed melt-spinning smoothly.
In addition, add the best functional agglomerate of preparation in advance during fibre spinning, its fibrous physics and appearance index reach the performance standard of general fibre substantially, simultaneously, due to adding of inorganic solid phase component, make fiber not only have health care, also improved water imbibition and the gas permeability of synthetic fibers.
Table 1
| The embodiment sequence number | Bacteriostatic agent addition (accounting for the wt% of fiber) | Far infrared cast charge addition (accounting for the wt% of fiber) | Protofilament spinning state | Fibrous physics index state | The fiber bacteriostasis rate | Fiber far infrared emissivity |
| 1 | 1-1.5 | 1.5-2 | State is good.Substantially be equal to common non-functional fibre spinning state | The physical index state Good.Substantially be equal to common non-functional fibrous physics index | Lower.The three average bacteriostasis rates of bacterial classification only have 40% | Emissivity is low.The emissivity of 5-25 mum wavelength only has 45% |
| 2 | 1.5-2 | 1.5-2 | State is better.Slightly poorer than common non-functional fibre spinning, but can normal spinning.Unit replacement is slightly shorter, has once in a while to float on a small quantity silk.Row yielding reaches 95% left and right | The fibrous physics index Good.Can reach the high-grade requirement of spinning processing.Outward appearance is equal to common non-functional fiber substantially, and the rate of classification of product can reach more than 95% | Fiber is antibacterial Rate is high.The three average bacteriostasis rates of bacterial classification can reach more than 95% | Far infrared Emissivity is high.The emissivity of 5-25 mum wavelength can reach more than 87% |
| 3 | 2-2.5 more than | 2-2.4 more than | Out of order.It is more that assembly leaks material level, floats silk and happen occasionally, and row yielding is less than 50% | The fibrous physics index Poor.Relative intensity is less than 2.5g/d, and extension at break is less than 25%, appearance poor, and manufacturing is poor, and the rate of classification of product is less than 70% | The fiber bacteriostasis rate is substantially the same manner as Example 2 | The far infrared emissivity is substantially the same manner as Example 2 |
In embodiment 1 to embodiment 3 in table 1, show in the situation that other conditions are identical, whether the addition of two kinds of inorganic solid-phase reagents suitably determines the master batch quality, and the quality of master batch directly affects fiber row yielding, physical index and the rate of classification of product of melting high-speed spinning protofilament.Through repeatedly preferred, the functional agglomerate that in embodiment 2, the proportioning of two kinds of inorganic solid-phase reagents in fiber more suitably made is used for melting high-speed spinning, the health fiber of the efficient antibacterial far infrared emission of acquisition, and functional effect is best; And the row yielding of fiber, the rate of classification of product is high, and the physical index of fiber is basic suitable with conventional allied fiber.Make fiber increase gas permeability, water imbibition, dyeability owing to containing quantitative inorganic solid matter in fiber.This fiber is suitable for knitting, woven (including shuttle woven, woven without shuttle) and through the processing raw material of the textile process means such as braiding, and has good weaving performance.After textile process, fabric possesses handling property preferably, drapability.Increased the snugness of fit of dress and personal adornment.The appearance of the synthetic fibers that this is new will provide reliable raw material for face weave and dress and personal adornment new product development.
It should be noted that at last: above embodiment only in order to technical scheme of the present invention to be described, is not intended to limit; Although with reference to previous embodiment, the present invention is had been described in detail, those of ordinary skill in the art is to be understood that: it still can be modified to the technical scheme that aforementioned each embodiment puts down in writing, and perhaps part technical characterictic wherein is equal to replacement; And these modifications or replacement do not make the essence of appropriate technical solution break away from the spirit and scope of various embodiments of the present invention technical scheme.
Claims (17)
1. bacteriostatic agent is characterized in that comprising at least:
Mixture of silver nitrate, accounting for the bacteriostatic agent percentage by weight is 54-70%, wherein, described mixture of silver nitrate comprises that to account for the bacteriostatic agent percentage by weight be the silver nitrate of 36-40% and accounts for the nanoscale zeolite that the bacteriostatic agent percentage by weight is 18-30%; Described silver nitrate exists with the form of silver nitrate aqueous solution;
Titanium oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%;
Zinc oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%;
The manufacture method of described bacteriostatic agent comprises:
It is that the granularity of 36-40% and silver nitrate is implanted less than or equal to the silver ion in the silver nitrate aqueous solution of 100 nanometers and accounted in the nanoscale zeolite that the bacteriostatic agent percentage by weight is 18-30% that silver nitrate is accounted for the bacteriostatic agent percentage by weight, forms mixture; Described mixture is become to contain silver zeolite after the drying that dewaters, pulverizing, grinding;
Described silver zeolite and the granularity of containing accounted for less than or equal to 100 nanometers titanium oxide and the zinc oxide that the bacteriostatic agent percentage by weight is respectively 15-23% and 15-23% and mix, form bacteriostatic agent;
Wherein said silver nitrate is that silver ion is at the silver nitrate more than 50%.
2. bacteriostatic agent according to claim 1 is characterized in that: described mixture of silver nitrate, and the optimum weight percentage that accounts for bacteriostatic agent is 60%; Described titanium oxide, the optimum weight percentage that accounts for bacteriostatic agent is 20%; Described zinc oxide, the optimum weight percentage that accounts for bacteriostatic agent is 20%.
3. bacteriostatic agent according to claim 1 is characterized in that described described silver zeolite and the granularity of containing being accounted for less than or equal to 100 nanometers titanium oxide and the zinc oxide that the bacteriostatic agent percentage by weight is respectively 15-23% and 15-23% and mix, and forms bacteriostatic agent and is specially:
Described silver zeolite and the granularity of containing accounted for the bacteriostatic agent percentage by weight less than or equal to 100 nanometers and be respectively 20% and 20% titanium oxide and zinc oxide and mix, form bacteriostatic agent.
4. master batch is characterized in that comprising:
Bacteriostatic agent, described bacteriostatic agent are the described bacteriostatic agent of claim 1-3 any one, and accounting for the master batch percentage by weight is 8-20%;
The far infrared cast charge, accounting for the master batch percentage by weight is 10-12%;
Carrier, accounting for the master batch percentage by weight is 64-78%;
Coupling agent accounts for the 2-5% of bacteriostatic agent and far infrared cast charge weight sum;
The oxytolerant heat-resistant agent, accounting for vehicle weight percentage is 1-2 ‰;
Dispersant accounts for the 15-20% of bacteriostatic agent and far infrared cast charge weight sum;
Wherein, described bacteriostatic agent comprises at least:
Mixture of silver nitrate, accounting for the bacteriostatic agent percentage by weight is 54-70%, wherein, described mixture of silver nitrate comprises that to account for the bacteriostatic agent percentage by weight be the silver nitrate of 36-40% and accounts for the nanoscale zeolite that the bacteriostatic agent percentage by weight is 18-30%; Described silver nitrate exists with the form of silver nitrate aqueous solution;
Titanium oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%;
Zinc oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%;
Described far infrared cast charge comprises: granularity is less than or equal to alundum (Al2O3) and the silica of 100 nanometers, and it is 80-90% that described alundum (Al2O3) accounts for far infrared cast charge percentage by weight, and it is 10-20% that described silica accounts for far infrared cast charge percentage by weight.
5. master batch according to claim 4, is characterized in that described carrier is polyamide fibre 6, polyamide fibre 66, terylene, the dried high-speed spinning section of polypropylene fibre.
6. according to claim 4 or 5 described master batches, is characterized in that described coupling agent is silane coupler.
7. master batch according to claim 6, is characterized in that described oxytolerant heat-resistant agent is pentaerythritol ester.
8. master batch according to claim 7, is characterized in that described dispersant is vinyl polymer wax.
9. the manufacture method of the described master batch of claim 4-8 any one is characterized in that comprising:
Be the bacteriostatic agent of 8-20% and to account for the master batch percentage by weight be the far infrared cast charge of the 10-12% activation mixed processing that dehumidifies to accounting for the master batch percentage by weight, described bacteriostatic agent is the described bacteriostatic agent of claim 1-2 any one;
With after dehumidifying activation mixed processing to account for the master batch percentage by weight be the bacteriostatic agent of 8-20% and account for the far infrared cast charge that the master batch percentage by weight is 10-12%, carrier with the 64-78% that accounts for the master batch percentage by weight, with the coupling agent that accounts for bacteriostatic agent and far infrared cast charge weight sum 2-5%, be the oxytolerant heat-resistant agent of 1-2 ‰ and the dispersant that accounts for bacteriostatic agent and far infrared cast charge weight sum 15-20% with accounting for vehicle weight percentage, carry out height and stir the mechanical dispersion treatment of activation;
Mixture after dispersion treatment is carried out cooling processing;
Cooled mixture is carried out the casting pelletizing, form the high speed spinning master batch.
10. the manufacture method of master batch according to claim 9, it is characterized in that described will dehumidify activation after mixed processing to account for the master batch percentage by weight be the bacteriostatic agent of 8-20% and account for the far infrared cast charge that the master batch percentage by weight is 10-12%, with account for the carrier that the master batch percentage by weight is 64-78%, with the coupling agent that accounts for bacteriostatic agent and far infrared cast charge weight sum 2-5%, be the oxytolerant heat-resistant agent of 1-2 ‰ and the dispersant that accounts for bacteriostatic agent and far infrared cast charge weight sum 15-20% with accounting for vehicle weight percentage, carry out height stir the activation mechanical dispersion treatment specifically comprise:
Bacteriostatic agent after dehumidifying activation mixed processing and far infrared cast charge were stirred 6-8 minute under the mixing speed of the whipping temp of 120-140 ℃, 1300rpm;
In the mixture of the bacteriostatic agent after stirring and far infrared cast charge, add the coupling agent that accounts for bacteriostatic agent and far infrared cast charge weight sum 2-5%, and stirred 2-3 minute under the mixing speed of the whipping temp 1300rpm of 120-130 ℃;
In the mixture of the bacteriostatic agent after stirring, far infrared cast charge, coupling agent, add the carrier that the master batch percentage by weight is 64-78% that accounts for after dewatering, and at the whipping temp of 120-130 ℃, stirred 6-8 minute under the mixing speed of 1300rpm, described carrier is dried PA6, PA66, PET or PP;
In the mixture of the bacteriostatic agent after stirring, far infrared cast charge, coupling agent and carrier, add and account for the oxytolerant heat-resistant agent that vehicle weight percentage is 1-2 ‰, and at the whipping temp of 120-130 ℃, stirred 2-3 minute under the mixing speed of 1300rpm, described oxytolerant heat-resistant agent is pentaerythritol ester;
In the mixture of the bacteriostatic agent after stirring, far infrared cast charge, coupling agent, carrier and oxytolerant heat-resistant agent, add the dispersant that accounts for bacteriostatic agent and far infrared cast charge weight sum 15-20%, and at the whipping temp of 120-130 ℃, stirred 2-3 minute under the mixing speed of 1300rpm, described dispersant is vinyl polymer wax.
11. the manufacture method of according to claim 9 or 10 described master batches is characterized in that describedly mixture after dispersion treatment is carried out cooling processing specifically comprising:
It is that the indirect cooling water amount of 25-28 ℃ is the cold water agitator of 3 tons/hour that mixture after dispersion treatment is put into temperature, stirs cooling described mixture temperature to be down to below 45 ℃.
12. the manufacture method of master batch according to claim 11 is characterized in that describedly cooled mixture is carried out the casting pelletizing specifically comprising:
Cooled mixture is put into twin-screw casting machine, carry out melting, make melt fully cut dispersion, and in the situation that keep predetermined mobility, the direct cooling cut-out granulation of casting entry.
13. a fiber is characterized in that comprising:
Moisture less than or equal to the 400ppm master batch, the percentage by weight that accounts for fiber is 10-20%;
Moisture less than or equal to 400ppm and the dried high-speed spinning section identical with carrier in described master batch, the percentage by weight that accounts for fiber is 80-90%;
Wherein, described master batch comprises:
Bacteriostatic agent, accounting for the master batch percentage by weight is 8-20%;
The far infrared cast charge, accounting for the master batch percentage by weight is 10-12%;
Carrier, accounting for the master batch percentage by weight is 64-78%;
Coupling agent accounts for the 2-5% of bacteriostatic agent and far infrared cast charge weight sum;
The oxytolerant heat-resistant agent, accounting for vehicle weight percentage is 1-2 ‰;
Dispersant accounts for the 15-20% of bacteriostatic agent and far infrared cast charge weight sum;
Wherein, described bacteriostatic agent is the described bacteriostatic agent of claim 1-3 any one, comprises at least:
Mixture of silver nitrate, accounting for the bacteriostatic agent percentage by weight is 54-70%, wherein, described mixture of silver nitrate comprises that to account for the bacteriostatic agent percentage by weight be the silver nitrate of 36-40% and accounts for the nanoscale zeolite that the bacteriostatic agent percentage by weight is 18-30%; Described silver nitrate exists with the form of silver nitrate aqueous solution;
Titanium oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%;
Zinc oxide, accounting for the bacteriostatic agent percentage by weight is 15-23%;
Described far infrared cast charge comprises: granularity is less than or equal to alundum (Al2O3) and the silica of 100 nanometers, and it is 80-90% that described alundum (Al2O3) accounts for far infrared cast charge percentage by weight, and it is 10-20% that described silica accounts for far infrared cast charge percentage by weight.
14. fiber according to claim 13 is characterized in that described master batch is the different classes of master batch of different carriers.
15. the manufacture method of a claim 13 or 14 fibers is characterized in that comprising:
After (10-20%) moisture all master batches and the even mixing of dried high-speed spinning section less than or equal to 400ppm than (80-90%), be spun into the FDY drawn fiber by melting high-speed spinning through one-step method; By melting high-speed spinning, be spun into the POY protofilament; By the middling speed melt spinning, be spun into the MOY protofilament; Described master batch is the described master batch of claim 4-8 any one.
16. the manufacture method of fiber according to claim 15 is characterized in that obtaining also comprising after described POY protofilament and MOY protofilament:
POY protofilament and MOY protofilament are added respectively bullet and drawing-off processing, form respectively elastomer DTY and drawn fiber FDY.
17. the manufacture method of fiber according to claim 16 is characterized in that describedly the POY protofilament is added bullet processing and comprising:
The POY protofilament is carried out interior drafting false twisting add that bullet is processed and common adding plays the drawing-off processing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910090776 CN101690500B (en) | 2009-08-06 | 2009-08-06 | Bacteriostat, master batch and fiber and manufacturing methods thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910090776 CN101690500B (en) | 2009-08-06 | 2009-08-06 | Bacteriostat, master batch and fiber and manufacturing methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101690500A CN101690500A (en) | 2010-04-07 |
| CN101690500B true CN101690500B (en) | 2013-11-06 |
Family
ID=42079250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200910090776 Active CN101690500B (en) | 2009-08-06 | 2009-08-06 | Bacteriostat, master batch and fiber and manufacturing methods thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101690500B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102560725B (en) * | 2010-12-31 | 2016-01-06 | 上海德福伦化纤有限公司 | The manufacture method of inorganic nanometer zinc oxide multifunctional composite antibacterial polyester fiber |
| CN102534850A (en) * | 2010-12-31 | 2012-07-04 | 上海德福伦化纤有限公司 | Method for manufacturing inorganic nano photoresponse-type self-cleaning polyester fiber flocking fluff |
| CN103694565A (en) * | 2013-12-30 | 2014-04-02 | 浙江七色鹿色母粒有限公司 | Polypropylene master batch with automatic themogenesis heat preservation function and preparation method for polypropylene master batch |
| CN103865150A (en) * | 2014-03-13 | 2014-06-18 | 苏州科茂电子材料科技有限公司 | Preparation method of mildew proofing sheath |
| CN103938293A (en) * | 2014-04-26 | 2014-07-23 | 广州市中诚新型材料科技有限公司 | Far infrared polyester fiber and preparation method thereof |
| CN105836860B (en) * | 2016-05-30 | 2019-03-15 | 柴海林 | A kind of stable type dioxygen aqueous disinfectant and its application in drinking water disinfection |
| CN110294839A (en) * | 2019-06-29 | 2019-10-01 | 江苏鑫福纤维科技有限公司 | A method of the fiber polyester chip for textile processing |
-
2009
- 2009-08-06 CN CN 200910090776 patent/CN101690500B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101690500A (en) | 2010-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101238817B (en) | Bacteriostat, far-infrared ray emitting agent, mother particle, fiber and manufacturing method thereof | |
| CN101690500B (en) | Bacteriostat, master batch and fiber and manufacturing methods thereof | |
| CN101255614B (en) | Inorganic solid-phase combination powder, master batch and manufacture method, fibre and manufacture method | |
| CN102433763B (en) | Functional fiber, manufacturing method and fabric formed via weaving functional fiber | |
| CN102877153B (en) | Negative ion cool lining and method for preparing same | |
| US20100047366A1 (en) | Articles with antibacterial and antifungal activity | |
| CN105200550B (en) | A kind of low melting point antibacterial special polyester monofilament and its processing method | |
| CN102560720A (en) | Method for manufacturing inorganic nanometer seaweed carbon polyester fiber | |
| CN106948026A (en) | A kind of fiber of white bamboo carbon chinlon 6 and its production method | |
| CN101187079A (en) | Antibiotic ultraviolet-resistant composite function health fiber | |
| CN101158054A (en) | Chromatic high-wet conductivity anti-bacterial fiber and spinning method thereof | |
| CN111548607A (en) | Preparation method of antibacterial color master batch and stock solution colored PET antibacterial functional fiber | |
| CN110230119A (en) | A kind of preparation method of antibiotic polyester fiber | |
| CN110714236A (en) | Preparation method of moisture-absorbing sweat-releasing antibacterial polyester filament yarn | |
| CN110409012A (en) | A kind of antibiotic polyester fiber and preparation method thereof | |
| CN111235681A (en) | Emodin modified polyester filament yarn and preparation method thereof | |
| CN105063781A (en) | Manufacturing process of silver-ion anti-bacterial bamboo carbon fiber fabric | |
| CN105506767B (en) | A kind of Mesoporous zirconium phosphate loading nano silvery antibacterial polypropylene fiber and preparation method thereof | |
| CN204644526U (en) | The manufacturing installation of the antibacterial colored fabric of iodine system | |
| CN109705544A (en) | High fluidity antibacterial matrices, preparation method and polyester fiber, preparation method | |
| CN210048894U (en) | Antibacterial and deodorant polyester fiber | |
| CN101314870B (en) | Method for preparing fibre | |
| KR100481358B1 (en) | A multifunctional polyester fiber and its manufacturing process | |
| KR101756911B1 (en) | Process Of Producing Sheath/Core Type Synthetic Fiber Containing Sericite | |
| CN101348949B (en) | Process for preparing fiber |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |